If you already have:

• One or more issued or pending patent applications

• A clearer product direction

• Investor scrutiny around IP quality and defensibility

• Increasing prosecution costs

And you need:

• A cohesive patent portfolio strategy

• Clarity on what is actually protected

• Confidence that ongoing costs are aligned with value

Rising Costs Without Strategic Context

Many companies find that as prosecution progresses, costs increase while strategic discussion decreases.

Growth-stage companies switch to us because they want:

• Clear explanations of why work is being done

• Predictable prosecution planning

• Fewer reactive decisions driven by deadlines

Limited Access to Decision-Makers

As portfolios grow, companies often find themselves interacting primarily with junior attorneys or staff.

At Biotech Beach Law, growth-stage companies value:

• Direct access to experienced attorneys

• Practical discussions about tradeoffs

• Clear ownership of strategy

Portfolios Built Without a Roadmap

Early patents may have been filed quickly and in isolation. Growth-stage companies often want to understand:

• How existing filings work together

• Whether claim scope matches the current product

• What future filings are actually necessary

Switching counsel provides an opportunity to step back and re-evaluate.

We Start With What You Already Have

Switching counsel does not mean starting over.

Our process typically begins with:

• Reviewing existing patent applications and prosecution history

• Mapping claims to current products and pipelines

• Identifying strengths, gaps, and risks

• Discussing options before additional costs are incurred

This allows companies to move forward with clarity and confidence.

Unique Challenges

Growth-stage biotech and medical device companies face unique challenges, including:

• Regulatory timing considerations

• Competitive patent landscapes

• Platform vs product protection decisions

Our Solution:

Our focused practice allows us to help companies:

• Align IP strategy with development and regulatory milestones

• Strengthen claim scope where it matters most

• Avoid unnecessary filings that dilute value

Clear Communication:

Growth-stage companies switch to us because they want:

• Fewer surprises

• Clear next steps

• IP decisions explained in business terms

We emphasize structured planning over ad hoc responses, helping companies regain control of their IP strategy.

No Disruptions

Changing counsel at the growth stage is common and manageable.

We:

• Coordinate the transition carefully

• Preserve priority dates and continuity

• Minimize disruption to ongoing prosecution

• Communicate clearly throughout the process 

The goal is a seamless handoff that allows the company to focus on growth.

We Offer:

• Focused experience in biotech and medical devices

• Strategic, portfolio-level guidance

• Transparent communication and fees

• Practical judgment grounded in USPTO experience

We are built for companies that have moved beyond first filings and are preparing for what comes next.

When To Switch

• Preparing for a funding round

• Facing increasing patent costs

• Unsure whether existing IP supports current products

• Looking for clearer strategic guidance

An early review can prevent compounding issues later.